Chemokine blockers - Therapeutics in the making?

Trends in Pharmacological Sciences

Volumn 27, Issue 1, 2006, Pages 41-47

  Wells, Timothy N C ^a   Power, Christine A ^a   Shaw, Jeffrey P ^a   Proudfoot, Amanda E I ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); APLAVIROC; CCR1 RECEPTOR ANTAGONIST; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ANTAGONIST; CP 481715; DPC 168; GLYCOSAMINOGLYCAN; INCB 3284; INTERLEUKIN 8 ANTIBODY; MARAVIROC; MLN 1202; MLN 3897; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CXCL8; T 487; UNCLASSIFIED DRUG;

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINES; EOSINOPHILS; GLYCOSAMINOGLYCANS; HUMANS; PSORIASIS; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 30344488431     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.11.001     Document Type: Review

References (46)

1. B.J. Rollins Chemokines Blood 90 1997 909 928
2. A.D. Luster Chemokines-chemotactic cytokines that mediate inflammation New Engl. J. Med. 338 1998 436 445
3. Z. Johnson Multi-faceted strategies to combat disease by interference with the chemokine system Trends Immunol. 26 2005 268 274
4. C. Gerard, and B.J. Rollins Chemokines and disease Nat. Immunol. 2 2001 108 115
5. M.J. Leckie Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response Lancet 356 2000 2144 2148
6. J.J. Lee Defining a link with asthma in mice congenitally deficient in eosinophils Science 305 2004 1773 1776
7. A.A. Humbles A critical role for eosinophils in allergic airways remodeling Science 305 2004 1776 1779
8. A.A. Humbles The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness Proc. Natl. Acad. Sci. U. S. A. 99 2002 1479 1484
9. W. Ma CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation J. Clin. Invest. 109 2002 621 628
10. J.M. Schroder, and E. Christophers Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales J. Invest. Dermatol. 87 1986 53 58
11. A. Pietrzak Plasma level of IL-8 in patients with psoriasis and its correlation with psoriasis area and severity index and the clinical type of the disease Ann. Univ. Mariae Curie Sklodowska [Med] 55 2000 261 267
12. X.D. Yang Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states J. Leukoc. Biol. 66 1999 401 410
13. B.M. Mian Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB Clin. Cancer Res. 9 2003 3167 3175
14. S. Huang Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma Am. J. Pathol. 161 2002 125 134
15. D.A. Mahler Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study Chest 126 2004 926 934
16. E.A. Berger Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17 1999 657 700
17. M. Samson Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 1996 722 725
18. M. Mack Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity J. Exp. Med. 187 1998 1215 1224
19. M.M. Lederman Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 Science 306 2004 485 487
20. T.L. Sorensen Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J. Clin. Invest. 103 1999 807 815
21. C. Trebst CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis Am. J. Pathol. 159 2001 1701 1710
22. K.E. Balashov CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions Proc. Natl. Acad. Sci. U. S. A. 96 1999 6873 6878
23. L. Boring Decreased lesion formation in CCR2(-/-) Mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
24. L. Izikson Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 J. Exp. Med. 192 2000 1075 1080
25. A.C. Bishop Magic bullets for protein kinases Trends Cell Biol. 11 2001 167 172
26. N.D. Waal Identification of nonpeptidic small-molecule inhibitors of interleukin-2 Bioorg. Med. Chem. Lett. 15 2005 983 987
27. T. Dragic A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5 Proc. Natl. Acad. Sci. U. S. A. 97 2000 5639 5644
28. A.E.I. Proudfoot Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist J. Biol. Chem. 271 1996 2599 2603
29. S.J. Siciliano Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 91 1994 1214 1218
30. Y. Zhang, and B.J. Rollins A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer Mol. Cell. Biol. 15 1995 4851 4855
31. J.H. Gong, and I. Clark-Lewis Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues J. Exp. Med. 181 1995 631 640
32. A.E. Proudfoot Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors J. Biol. Chem. 274 1999 32478 32485
33. A. Rot Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration Immunol. Today 13 1992 291 294
34. A.J. Hoogewerf Glycosaminoglycans mediate cell surface oligomerization of chemokines Biochemistry 36 1997 13570 13578
35. A.E.I. Proudfoot Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines Proc. Natl. Acad. Sci. U. S. A. 100 2003 1885 1890
36. J.P. Shaw The X-ray structure of RANTES: heparin-derived disaccharides allows the rational design of chemokine inhibitors Structure (Camb) 12 2004 2081 2093
37. A.E. Proudfoot The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity J. Biol. Chem. 276 2001 10620 10626
38. Z. Johnson Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system J. Immunol. 173 2004 5776 5785
39. P.M. Steed Inactivation of TNF signaling by rationally designed dominant-negative TNF variants Science 301 2003 1895 1898
40. E. Hirsch Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation Science 287 2000 1049 1053
41. Z. Li Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant- mediated signal transduction Science 287 2000 1046 1049
42. T. Sasaki Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration Science 287 2000 1040 1046
43. M. Camps Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis Nat. Med. 11 2005 936 943
44. D.W. Banner Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation Cell 73 1993 431 445
45. K. Palczewski Crystal structure of rhodopsin: a G protein-coupled receptor Science 289 2000 739 745
46. E.H. Walker Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine Mol. Cell 6 2000 909 919